Added to YB: 2022-04-03
Pitch date: 2022-04-03
EMBCV [bullish]
Embecta Corp.
-55.1%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.
Market Cap
$697.6M
Pitch Price
$26.57
Price Target
N/A
Dividend
5.00%
EV/EBITDA
19.95
P/E
12.12
EV/Sales
1.88
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
EMBECTA CORP EMBCV
A summary for this pitch has not been created yet.
Read full article (0 min)